Disynformon en es it fr

Disynformon Brand names, Disynformon Analogs

Disynformon Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Disynformon Chemical_Formula


Disynformon RX_link

No information avaliable

Disynformon fda sheet

Disynformon msds (material safety sheet)

Disynformon MSDS

Disynformon Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Disynformon Molecular Weight

270.366 g/mol

Disynformon Melting Point

254.5-256 oC

Disynformon H2O Solubility

3 g/100mL

Disynformon State


Disynformon LogP


Disynformon Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Disynformon Indication

For management of Menopausal and postmenopausal disorders

Disynformon Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Disynformon Absorption


Disynformon side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Disynformon Patient Information

Disynformon Organisms Affected

Humans and other mammals